Nuestra página de facturación está certificada por:
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ... - MarketWatch (press release)
New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in .
Bristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the ... - MarketWatch (press release)
Asian Scientist MagazineBristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the .
Shortage of vital medicine – a national crisis? - NJ.com (blog)
NJ.
Infection Risk High in Juvenile Arthritis - MedPage Today
MedPage TodayInfection Risk High in Juvenile ArthritisMedPage TodayNote that among children with JIA, the rate of infection was not increased with methotrexate or tumor necrosis factor inhibitor use.
Five-Year Mortality for Rheumatoid Vasculitis Around 60 Percent - About - News & Issues
Five-Year Mortality for Rheumatoid Vasculitis Around 60 PercentAbout - News & IssuesMethotrexate was used in 65% of the patients.